image
Replimune Group, Inc. REPL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.8
-5.26 %
$ 739 M
Market Cap
-3.39
P/E
CASH FLOW STATEMENT
-185 M OPERATING CASH FLOW
-44.84%
Growth Rates
1Year -44.84%
3Years -44.56%
5Years -48.85%
7Years -59.45%
10Years 0.00%
97.2 M INVESTING CASH FLOW
168.21%
Growth Rates
1Year 168.21%
3Years 35.99%
5Years 28.28%
7Years 136.22%
10Years 0.00%
16.3 M FINANCING CASH FLOW
-94.77%
Growth Rates
1Year -94.77%
3Years -64.77%
5Years -30.63%
7Years 1.18%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Replimune Group, Inc.
image
Net Income -216 M
Depreciation & Amortization 2.66 M
Capital Expenditures -5.66 M
Stock-Based Compensation 34.1 M
Change in Working Capital 5.48 M
Others -3.66 M
Free Cash Flow -191 M

Cash Flow

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
OPERATING CASH FLOW
Net Income (215.8) (174.3) (118.0) (80.9) (52.6) (30.8) (19.7) (7.7)
Depreciation & Amortization 2.7 2.4 2.1 1.7 0.5 0.1 0.1 0.1
Deferred Income Tax 0 38 K 0 2.3 (0.9) 3.7 0.8 0
Stock Based Compensation 34.1 28.1 24.3 11.8 7.7 2.7 0.8 0.2
Other Operating Activities (11.9) 0.5 2.2 0.2 0.2 93 K 26 K 0.1
Change in Working Capital 5.5 15.1 7.2 3.5 (15.4) (1.3) 1.9 0.1
Cash From Operations (185.5) (128.1) (82.2) (61.4) (60.6) (25.4) (16.0) (7.1)
INVESTING CASH FLOW
Capital Expenditures (5.7) (2.3) (2.3) (2.4) (6.5) (2.6) (0.1) (0.2)
Other Items 102.9 (140.2) 0.5 (186.4) 1.3 (63.3) (43.9) 0
Cash From Investing Activities 97.2 (142.5) (1.8) (188.8) (5.2) (65.9) (44.0) (0.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 14.5 27.8 (0.3) (10.1) 9.9 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 1.8 96.2 6.9 96.5 28.3 (2.0) 54.8 15.0
Cash From Financing Activities 16.3 311.3 6.6 372.5 100.2 101.4 54.8 15.0
CHANGE IN CASH
Net Change In Cash (72.1) 40.6 (76.6) 123.0 34.2 9.2 (3.0) 6.3
FREE CASH FLOW
Free Cash Flow (191.1) (130.3) (84.5) (63.8) (67.1) (28.0) (16.1) (7.3)